Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-15,000
Closed -$303K 134
2018
Q3
$303K Sell
15,000
-2,800
-16% -$63.2K 0.04% 87
2018
Q2
$421K Buy
17,800
+4,500
+34% +$116K 0.07% 88
2018
Q1
$300K Buy
+13,300
New +$350K 0.04% 114
2017
Q1
Sell
-48,043
Closed -$741K 283
2016
Q4
$636K Buy
+48,043
New +$655K 0.04% 182
2016
Q3
Sell
-43,964
Closed -$550K 320
2016
Q2
$433K Buy
43,964
+8,097
+23% +$94.5K 0.02% 218
2016
Q1
$454K Buy
+35,867
New +$472K 0.02% 216
2014
Q4
Sell
-10,000
Closed -$142K 264
2014
Q3
$131K Buy
+10,000
New +$151K 0.01% 228

Other funds holding INSM

Sabby Management's INSM Position: Q4 2018 in Review

Sabby Management sold out of Insmed (INSM) in Q4 2018, closing a stake of 15,000 shares — an estimated $303K sold.

Sabby Management first reported a position in INSM in Q3 2014 and held it in 7 quarters. The position peaked at $636K in Q4 2016. 126 funds tracked by Wall St. Rank hold INSM as of Q4 2018.

  • Sabby Management reported no remaining Insmed position as of Q4 2018 after selling out during the quarter.
  • Sabby Management sold 15,000 Insmed shares in Q4 2018, an estimated $303K.
  • Sabby Management first reported a position in Insmed in Q3 2014 and held it in 7 quarters.
  • Sabby Management's Insmed position peaked at $636K in Q4 2016.
  • 126 funds tracked by Wall St. Rank held Insmed as of Q4 2018.

Based on Sabby Management's 13F filing for Q4 2018, filed 14 Feb 2019.